期刊文献+

表观遗传生物标志物在人类疾病早期诊治中的研究进展 被引量:3

Research progress of epigenetic biomarkers in the early diagnosis and treatment of human diseases
在线阅读 下载PDF
导出
摘要 表观遗传修饰异常见于人类的多种疾病(如肿瘤、老年性疾病、发育源性疾病等),影响着这些疾病的发生发展。已有的研究表明,异常表观遗传改变可以作为疾病状态和疾病预测的生物标志物。表观遗传修饰改变的可逆性和可控性也为疾病早期的预防和治疗提供了新策略。本文对DNA甲基化修饰、组蛋白共价修饰、非编码RNA等三种表观遗传方式在肿瘤、老年性疾病和发育源性疾病的研究,以及三者作为表遗传生物标志物在疾病早期诊断和治疗的应用展开介绍,以期为肿瘤、老年性和发育源性相关疾病的诊断与治疗提供借鉴和参考。 Abnormal epigenetic modifications are common in many diseases(such as tumors,senile and developmental diseases),and can influence the pathogenesis and progression of these diseases.Various studies demonstrated that abnormal epigenetic changes could be used as biomarkers for diagnosis of the disease status and prognosis of disease progression.The reversibility and controllability of epigenetic modifications also offer an opportunity to develop new strategies for the early prevention and treatment of diseases.In this review,we provide a brief overview of the latest discoveries in three areas of epigenetic research,i.e.,DNA methylation,histone modifications and non-coding RNAs,and their potential applications in early diagnosis and treatment of tumors,senile and developmental diseases.We hope to provide some insights and references in developing strategies for the diagnosis and treatment of these diseases.
作者 黎伟 秦俊 汪晖 陈廖斌 朱卫国 Wei li;Jun Qin;Hui Wang;Liaobin Chen(Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan 430071, China;Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China;Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China)
出处 《遗传》 CAS CSCD 北大核心 2018年第2期104-115,共12页 Hereditas(Beijing)
基金 国家自然科学基金项目(编号:81220108026,81401832)
关键词 表观遗传修饰 表遗传生物标志物 肿瘤 老年性疾病 发育源性疾病 epigenetic modification epigenetic biomarkers tumors senile diseases developmental diseases
作者简介 黎伟,硕士研究生,专业方向:骨关节病。E-mail:444069914@qq.co;通讯作者: 秦俊,博士,主治医师,专业方向:骨关节病。E-mail:heart.blue@163.com
  • 相关文献

参考文献3

二级参考文献69

  • 1Gopalakrishnan S, Van Emburgh BO, Robertson KD. DNA methylation in development and human disease. Mutat Res, 2008, 647(1-2): 30-38.
  • 2Auclair G, Weber M. Mechanisms of DNA methylation and demethylation in mammals. Bioehimie, 2012, 94(11): 2202-2211.
  • 3Watt F, Molloy PL. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev, 1988, 2(9): 1136-1143.
  • 4Zhu WG, Srinivasan K, Dai ZY, Duan WR, Druhan LJ, Ding HM, Yee L, Villalona-Calero MA, Plass C, Otterson GA. Methylation of adjacent CpG sites affects Spl/Sp3 binding and activity in the p21(Cipl) promoter. Mol Cell Biol, 2003, 23(12): 4056-4065.
  • 5Strahl BD, Allis CD. The language of covalent histone modifications. Nature, 2000, 403(6765): 41-45.
  • 6Taverna SD, Li H, Ruthenburg A J, Allis CD, Patel DJ. How chromatin-binding modules interpret histone modi- fications: lessons from professional pocket pickers. Nat Struct Mol Biol, 2007, 14(11): 1025-1040.
  • 7Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell, 2007, 25(1): 1- 14.
  • 8Martin C, Zhang Y. The diverse functions of histone ly- sine methylation. Nat Rev Mol Cell Biol, 2005, 6(11): 838-849.
  • 9Kouzarides T. Chromatin modifications and their function. Cell, 2007, 128(4): 693-705.
  • 10Skreka K, Schafferer S, Nat IR, Zywicki M, Salti A, Apostolova G, Griehl M, Rederstorff M, Dechant G, H/ittenhofer A. Identification of differentially expressed non-coding RNAs in embryonic stem cell neural differen- tiation. Nucleic Acids Res, 2012, 40(13): 6001-6015.

共引文献17

同被引文献19

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部